Pharmacoeconomic aspects of drug provision of patients with diabetes mellitus in the Novosibirsk Region

Abstract

Aim to conduct a pharmacoeconomic assessment of drug provision for patients with diabetes mellitus in the Novosibirsk Region in the context of federal and regional segments for the period 2019-2021. Material and methods. An array of data on drug provision for diabetic patients in the Novosibirsk region for the period 2019-2021 was subjected to analysis. In the process of research were used methods: logical analysis, content analysis, ABC analysis, XYZ analysis. Results. The pharmacoeconomic assessment of drug provision for diabetic patients allows us to conclude that in the period 2019-2021 the load on the regional segment of the drug provision system steadily increased. At the same time, the share of costs for drug provision of diabetic patients in the federal segment continues to grow, despite the decrease in the number of covered prescriptions, which can be explained by the constant increase in the average cost of a prescription. The results of assessing the consumption of medicines and medical devices using a matrix model based on an integrated ABC/XYZ analysis showed an increasing need for additional medicines for the treatment of complications and concomitant diseases in diabetic patients. A greater increase in prescriptions of additional medicines and expenses for them in the period 2019-2021 observed in the regional segment. Conclusion. The results can be used to make managerial decisions in the field of optimizing the organization of drug provision for diabetic patients.